ATE394101T1 - Piperidinyl-prostaglandin-e-analoga - Google Patents

Piperidinyl-prostaglandin-e-analoga

Info

Publication number
ATE394101T1
ATE394101T1 AT05705822T AT05705822T ATE394101T1 AT E394101 T1 ATE394101 T1 AT E394101T1 AT 05705822 T AT05705822 T AT 05705822T AT 05705822 T AT05705822 T AT 05705822T AT E394101 T1 ATE394101 T1 AT E394101T1
Authority
AT
Austria
Prior art keywords
analogue
prostaglandin
piperidinyl
piperidinyl prostaglandin
Prior art date
Application number
AT05705822T
Other languages
German (de)
English (en)
Inventor
David Old
Danny Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE394101T1 publication Critical patent/ATE394101T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05705822T 2004-01-22 2005-01-14 Piperidinyl-prostaglandin-e-analoga ATE394101T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/763,702 US6977260B2 (en) 2004-01-22 2004-01-22 Piperidinyl prostaglandin E analogs

Publications (1)

Publication Number Publication Date
ATE394101T1 true ATE394101T1 (de) 2008-05-15

Family

ID=34795110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05705822T ATE394101T1 (de) 2004-01-22 2005-01-14 Piperidinyl-prostaglandin-e-analoga

Country Status (11)

Country Link
US (1) US6977260B2 (enExample)
EP (1) EP1722795B1 (enExample)
JP (1) JP4740883B2 (enExample)
AR (1) AR047436A1 (enExample)
AT (1) ATE394101T1 (enExample)
AU (1) AU2005209209B2 (enExample)
CA (1) CA2553387C (enExample)
DE (1) DE602005006534D1 (enExample)
ES (1) ES2303672T3 (enExample)
TW (1) TWI348370B (enExample)
WO (1) WO2005072735A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease
WO2006047466A2 (en) * 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220156C2 (de) * 1982-05-28 1990-01-25 Heida Houston Tex. Thurlow Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
IT1225716B (it) * 1988-10-26 1990-11-22 Esacontrol Spa Dispositivo per la protezione dei rele' di binario dai disturbi elettrici
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
DE4318713C1 (de) * 1993-06-07 1994-09-15 Daimler Benz Ag Zahnräderwechselgetriebe der Vorgelegebauart
JP4766875B2 (ja) * 2002-06-06 2011-09-07 メルク フロスト カナダ リミテツド Ep4受容体作動薬、組成物及びその方法
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
WO2004063158A1 (en) 2003-01-10 2004-07-29 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs

Also Published As

Publication number Publication date
HK1099203A1 (en) 2007-08-10
AU2005209209B2 (en) 2012-03-08
ES2303672T3 (es) 2008-08-16
EP1722795A1 (en) 2006-11-22
AU2005209209A1 (en) 2005-08-11
WO2005072735A1 (en) 2005-08-11
US6977260B2 (en) 2005-12-20
TWI348370B (en) 2011-09-11
CA2553387A1 (en) 2005-08-11
TW200533350A (en) 2005-10-16
EP1722795B1 (en) 2008-05-07
AR047436A1 (es) 2006-01-18
US20050164990A1 (en) 2005-07-28
JP2007520489A (ja) 2007-07-26
JP4740883B2 (ja) 2011-08-03
DE602005006534D1 (de) 2008-06-19
CA2553387C (en) 2013-04-02

Similar Documents

Publication Publication Date Title
EP1795261A4 (en) hONEYCOMB STRUCTURE
ATE414693T1 (de) Neuartige cis-imidazoline
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
DK1819670T3 (da) 12-Aryl-prostaglandinanaloger
EP1767508A4 (en) CERAMIC HONEYCOMB STRUCTURE
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
DK1776090T3 (da) Stabiliseret prostaglandinsammensætning
DE602006016573D1 (de) Substituierte piperidine
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
EP1860082A4 (en) hONEYCOMB STRUCTURE
ATE394101T1 (de) Piperidinyl-prostaglandin-e-analoga
DK1799707T3 (da) Rekombineret Kunitztypeinhibitor
FR2865904B1 (fr) Calecon remonte fesses
EP1708704A4 (en) 4-arylpiperidines
SE0402103D0 (sv) Novel compounds
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
ITPD20050083A1 (it) Piano di gioco
ITPD20050016U1 (it) Piano di gioco
ITPD20050034U1 (it) Piano di gioco
ITPD20050134A1 (it) Piano di gioco
ITRO20040011A1 (it) Tecnopannello legno
SE0400209D0 (sv) Novel methods
UA11670S (uk) Концертні цимбали
SE0403054D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties